Late syphilis
ICD-10 A52 is a billable code used to indicate a diagnosis of late syphilis.
Late syphilis is the final stage of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum. This stage typically occurs years after the initial infection if left untreated. Clinically, late syphilis can manifest as gummatous syphilis, where soft, tumor-like growths (gummas) develop in various tissues, or as neurosyphilis, affecting the central nervous system. Patients may experience a range of symptoms, including but not limited to, skin lesions, neurological deficits, and cardiovascular complications. Diagnosis is primarily through serological testing, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment involves the administration of benzathine penicillin G, which is effective in eradicating the infection and preventing further complications. Contact tracing is crucial in managing syphilis, as it helps identify and treat sexual partners to prevent reinfection and further transmission of the disease.
Detailed clinical notes on symptoms, test results, and treatment plans.
Patients presenting with neurological symptoms or gummatous lesions.
Ensure comprehensive documentation of all serological tests and follow-up care.
Thorough history of sexual health, risk factors, and partner notification efforts.
Routine screening in high-risk populations and management of syphilis cases.
Documenting patient education on STIs and safe sex practices.
Used to confirm diagnosis of late syphilis.
Document the type of serological tests performed and results.
Infectious disease specialists may require additional details on test interpretation.
Common symptoms include gummas, neurological issues, and cardiovascular problems. Patients may also experience systemic symptoms like fever and malaise.
Treatment typically involves benzathine penicillin G, administered intramuscularly. The dosage and duration depend on the severity of the disease.
